Industrial Transformation Takes Center Stage at Cognite’s Global “Ignite Talks” October 27-29
Cognite, a leader in industrial innovation, will host its third annual global conference “Ignite Talks: Industrial Intelligence Augmented: Reimagining How Minds and Machines Work Together” from Oct. 27-29, 2020. The free virtual event will feature global leaders and innovators who are driving industries and supply chains toward a more innovative, data-driven, sustainable future.
“The world is at a technological, economic, and environmental crossroads like never before, and we are looking forward to discussing pressing issues among some of the industry’s best,” said John Markus Lervik, Cognite CEO.
The full agenda for this free online conference can be found here and at www.cogniteignite.com.
Day-by-day overviews and panel highlights are listed below:
October 27: Igniting Industrial Transformation: Europe & Norway’s Leading Role
Opening day spotlights how leaders in Europe are melding minds and machines, and inspiring a transformation of heavy-asset industries and supply chains. Panel highlights:
- What's Next for the Global Energy Transition: The energy transition is here. Can the oil and gas industry adapt, or is it the end of the industry as we know it?
- Speakers: Bernard Looney, CEO, BP; Ahmad A. Al-Sa’adi, SVP of Technical Services, Saudi Aramco; Øyvind Eriksen, President and CEO, Aker ASA
- Reinventing Industrial Supply Chains Post-COVID Through Digital Innovation: 2020 has presented the world with a chance to rethink global supply chains. How do we seize the opportunity?
- Speakers: Sameer Kalra, President Marine Division, Alfa Laval; Victoria Van Camp, CTO, SKF
October 28: America’s Industrial Transformation
The technology prowess of the United States and raw innovative capacity is unmatched, and its heavy-asset industries are taking steps to leverage technology at scale in order to jump-start digital transformations. What will it take to succeed, what role does technology play? Panel highlights:
- America’s Energy Transition - in partnership with Axios: A live, virtual event, featuring in-depth 1:1 discussions with industry leaders and policymakers on the development of renewable energy in the US, how the coronavirus pandemic has affected energy patterns, and what’s next for the US oil & gas industry. This panel will be hosted by Axios energy and climate change reporter Amy Harder.
- Industry Under Siege: A New Era of Industrial Cybersecurity: Sophisticated cybercriminals are setting their sights on industry. How can industrial companies digitalize operations while minimizing risk?
- Speakers: Ron Brash, Director of Cyber Security Insights, Verve Industrial Protection; Tomomi Aoyama, Head of Business Development UK, Nihon Cyber Defence
- Navigating the Digital Transition to Renewable Energy
- Speakers: Ashtad Engineer, VP Digital & Transformation, Adani; Astrid Skarheim Onsum, CEO, Aker Offshore Wind
October 29: Driving a Global Transformation from the Bottom Up
The domains and technologies behind the scenes are the real drivers of industrial transformation. The final day gives an insider's view into technology adoption, empowering users with data and domain-specific insights into subsurface and exploration, detection and warning, ocean data, sustainability, and more. Panel highlights:
- Operationalize and Scale Models and Applications with Trusted Industrial Data: Data issues are still holding back digitalization initiatives. Experts from Forrester and Wintershall Dea explain how to break down barriers and generate meaningful ROI.
- Speakers: Patrick von Pattay, VP of Intelligent Operations, Wintershall DEA; Paul Miller, Principal Analyst, Forrester
- Cleaning Up Our Act: Data-Driven Sustainability in Upstream Oil & Gas: Reducing emissions has become the responsibility of every oil and gas company. BP explains how digitalization is powering its sustainable transformation.
- Speaker: Rob Kelly, Head of Upstream Digital, BP
- Waves of Change: Using Data to Advance Ocean Sustainability: The oceans are under siege. In this session, leading ocean experts explain how industry can use data to turn the tide.
- Speakers: Craig McLean, Assistant Administrator of Oceanic and Atmospheric Research, National Oceanic and Atmospheric Administration; Bjørn Tore Markussen, CEO at Center for the 4th Industrial Revolution for the Ocean
About Cognite
Cognite is a global industrial software-as-a-service (SaaS) company supporting the full-scale digital transformation of heavy-asset industries around the world. Their key product, Cognite Data Fusion (CDF), empowers companies with contextualized OT/IT data to drive industrial applications that increase safety, sustainability, and efficiency, and drive revenue. Visit us at www.cognite.com and follow us on Twitter @CogniteData or at LinkedIn: https://www.linkedin.com/company/cognitedata
View source version on businesswire.com: https://www.businesswire.com/news/home/20201006005623/en/
Contact information
Michelle Holford
Global PR Lead - Cognite
+15127443420 (US)
+4748290454 (Norway)
michelle.holford@cognite.com
About Business Wire
Business Wire(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Data from the APOLLO Study Show Clinically Meaningful Response with DARZALEX ® ▼ (daratumumab) Subcutaneous Formulation Regimen After First or Subsequent Relapse in Multiple Myeloma4.12.2020 20:52:00 CET | Press release
The Janssen Pharmaceutical Companies of Johnson & Johnson announced results of the Phase 3 APOLLO study showing that the addition of DARZALEX®▼ (daratumumab) subcutaneous (SC) formulation to pomalidomide and dexamethasone (D-Pd) significantly reduced the risk of progression or death by 37 percent, compared to Pd alone in patients with multiple myeloma (MM) after the first or subsequent relapse of disease.1 The APOLLO results, which will be presented on Sunday, December 6 at 9:00 p.m. CET during the American Society of Hematology (ASH) 2020 Annual Meeting and featured in the ASH press briefing (Abstract #112), add to the body of evidence supporting treatment with daratumumab SC-based regimens for patients with relapsed MM. These data were the basis for recent regulatory submissions in Europe and the United States (U.S.) seeking approval for daratumumab SC in combination with Pd for the treatment of patients with relapsed or refractory MM, with two or more prior lines of therapy, includi
Citi Private Bank Issues Outlook 2021: The New Economic Cycle: Investing for a Post-COVID World4.12.2020 17:36:00 CET | Press release
Citi Private Bank has released its Outlook 2021: The New Economic Cycle: Investing for a Post-COVID World. The twice-yearly publication provides in-depth insights into the global economy and financial markets for the coming year and highlights multi-year “unstoppable trends” for client portfolios. This edition outlines why this is a remarkable time to be an investor. Just as the pandemic changed the price of every security when it arrived, the departure of COVID will mark the beginning of a new economic cycle, creating new opportunities for investors. Citi Private Bank expects 2021 will benefit from an economy that demonstrated resilience in the face of the worst global healthcare crisis in more than a century. 2020 was an opportunity for the world to “test drive the future” and make way for growth as the pandemic ebbs. The tailwinds for 2021 are underappreciated: our financial system is strong, government actions to protect individuals and businesses have been effective, technological
Takashi Nagao Appointed President and Chief Executive Officer of Medicago4.12.2020 17:00:00 CET | Press release
Medicago, a biopharmaceutical company headquartered in Quebec City, Canada, today announced Takashi Nagao as the company’s new President and Chief Executive Officer. Prior to becoming President and CEO, Mr. Nagao served as the Chairman of the Board of Medicago, where for the last four years, he has guided Medicago executives to get the company to where it is today. Medicago, a research and development company for the last 20 years, is embarking on a transformative year, one that will see the company build on its R&D roots to become a company that also produces and commercializes vaccines and other immunotherapies. Mr. Nagao has extensive experience leading pharmaceutical companies through the pre-commercial and commercial process and is well positioned to ensure the successful launch of Medicago’s COVID-19 and influenza vaccines, subject to regulatory approvals. Mr. Nagao will continue Medicago’s evolution towards its goal of being a fully operational commercial entity, able to respond
WorldRemit Leads the Way Offering a USD Payout Option in Nigeria4.12.2020 16:46:00 CET | Press release
WorldRemit, a leading digital cross-border payments business has announced that its customers in Nigeria can now receive remittances in foreign currency (USD) through its cash pick up providers. Following the announcement of the Central Bank of Nigeria (CBN) a day before, WorldRemit quickly adapted to the new requirements making it the first digital service to offer its customers worldwide the option of cash pickup in USD in Nigeria. WorldRemit enables Nigerians in over 50 countries around the world to support their family and friends in Nigeria. The decision by the Central Bank of Nigeria (CBN) to allow international money transfers to be paid in foreign currency, is aimed at providing increased liquidity in the foreign exchange market. The bank explained that the new regulation is part of its efforts to liberalize, simplify and improve the receipt and administration of diaspora remittances into Nigeria. Gbenga Okejimi, Country Manager, Nigeria and Ghana, at WorldRemit, said:“ We are
PPC Upgraded to ‘B’ with ‘Stable’ Outlook by S&P4.12.2020 15:16:00 CET | Press release
In its annual research update released on 27 November 2020, S&P upgraded PPC’s stand-alone credit profile (SACP) upward by two notches to ‘B’ from ‘CCC+’, resulting in an overall upgrade of the long-term credit rating of PPC to ‘B’ from ‘B-‘. According to S&P the two notch upgrade in PPC’s standalone corporate rating confirms that the Company’s strategic repositioning and the improved Greek energy market fundamentals have transformed its competitive position, reducing past concerns over its liquidity and long-term sustainability. The ‘Stable’ outlook underscores S&P’s expectation that PPC will continue to deliver on its transformation plan, with solid liquidity and improved margins. PPC’s strategic plan to convert its generation mix toward lower carbon dioxide (CO2) emissions improve its fleet competitiveness and long-term prospects. As mentioned in their report, S&P expects a substantial increase in EBITDA and improvement in credit metrics on the back of higher profitability as PPC ac
Chengdu Launches Online Exhibition of History and Culture to Enhance Cultural Ties With European Countries4.12.2020 13:17:00 CET | Press release
The launching ceremony of Chengdu History and Culture Overseas Virtual Exhibition was held by the Chengdu Chronicles Compilation Committee at Chengdu Chronicles Office on 24 November. The event, along with the unveiling ceremony of Chengdu Chronicles Culture Overseas (Europe) Exchange Cooperation, were witnessed by distinguished guests in many European countries including the Netherlands, Germany and Belgium through video and online connections. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201204005278/en/ On November 24, Gao Zhigang (center), Director of Chengdu Chronicles Compilation Committee at Chengdu Chronicles Office, and other guests attend the launching ceremony of Chengdu History and Culture Overseas Virtual Exhibition. (Photo: Business Wire) Chengdu History and Culture Overseas Virtual Exhibition will also be launched at major foreign media platforms for audiences all over the world. Gao ZhiGang, Director of Che
New Phase 3 Data Show TAK-620 (maribavir), an Investigational Drug for the Treatment of Transplant Recipients with Refractory/Resistant Cytomegalovirus (CMV) Infections, Meets Primary Endpoint4.12.2020 12:00:00 CET | Press release
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced top-line results from the Phase 3 clinical trial evaluating the efficacy and safety of the investigational drug TAK-620 (maribavir), in the treatment of transplant recipients with refractory/resistant cytomegalovirus (CMV) infection. The TAK-620-303 (SOLSTICE) trial (NCT02931539) is a multicenter, randomized, open-label, active-controlled trial comparing eight weeks of treatment with either maribavir or investigator assigned treatment (IAT) in transplant recipients with CMV infection refractory or resistant to existing antiviral treatments (i.e., one or a combination of ganciclovir, valganciclovir, foscarnet or cidofovir). The SOLSTICE trial met its primary endpoint, defined as the proportion of patients who achieved confirmed CMV viremia clearance compared to IAT at the end of Study week 8. In addition, the SOLSTICE trial met its key secondary endpoint, defined as achievement of CMV viremia clearance